Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bicycle Therapeutics
Biotech
Bicycle lays off staff as Genentech rides away from R&D pact
The layoffs, which are part of a push to cut spending by 30%, follow Genentech’s termination of an oncology collaboration with the biotech.
Nick Paul Taylor
Aug 8, 2025 8:50am
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
May 3, 2024 8:30am
Bicycle reveals another $1.7B deal, this time with Bayer
May 10, 2023 9:05am
Amarin CEO abruptly resigns—Chutes & Ladders
Apr 7, 2023 9:30am
Novartis-Bicycle radiopharmaceuticals deal could cruise to $1.7B
Mar 28, 2023 10:35am
